Plain-English translation of NCT07702461 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Ohio State University want to understand how people exercise when taking GLP-1 receptor agonists—medications increasingly prescribed for weight loss and diabetes management. This study will collect information from about 300 people who are already using this medication to learn about their resistance training (strength exercise) habits before and after starting treatment.
While this medication is very effective for weight loss, it can sometimes reduce muscle mass, which can affect strength, balance, and how easily people can do everyday activities. Resistance training—like weightlifting or using exercise bands—is the best way to keep muscles strong. This study wants to understand whether people are doing enough resistance training while on this medication, so doctors can better advise patients about how to stay healthy overall.
You likely qualify if…
You likely don't qualify if…
This is a survey-based study, not a medication trial. You would complete questionnaires about your exercise habits, muscle-strengthening activities, and health information—likely through an online form or phone survey. There are no visits to a clinic, no new medications to take, and no physical exams required. The study aims to collect this information from people at different points in their treatment journey.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States